ADAPTIN BIO, INC.
APTNCIK 0001938571
Revenue (TTM)
—
FY Jun 2026
Net Income (TTM)
−$4.95M
−65.5% YoY
FY Jun 2026
EPS Diluted (TTM)
−$0.15
+31.2% YoY
FY Jun 2026
Gross Margin
—
FY Jun 2026
Operating Margin
—
FY Jun 2026
Net Margin
—
FY Jun 2026
Free Cash Flow (TTM)
—
FY Jun 2026
Cash
$301.31K
FY Jun 2026
Total Debt
—
FY Jun 2026
Shares Outstanding
8.9M sh
FY Jun 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.